                         SEQUENCE LISTING

<110>  Johns Hopkins Technology Ventures
 
<120>  P75NTR ANTAGONISTS AND TREATMENT OF ACUTE AND CHRONIC CARDIAC 
       DISEASE

<130>  P13700-01

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide sequence

<400>  1

Cys Ala Thr Asp Ile Lys Gly Ala Glu Cys 
1               5                   10  


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide sequence

<400>  2

Cys Ala Thr Asp Ile Lys Gly Ala 
1               5               


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide sequence

<400>  3

Cys Ala Thr Asp Ile Lys Gly 
1               5           


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide sequence

<400>  4

Thr Asp Ile Lys Gly Ala Glu Cys 
1               5               


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide sequence

<400>  5

Thr Asp Ile Lys Gly Ala Lys Glu Cys 
1               5                   


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide sequence

<400>  6

Thr Asp Ile Lys Gly Ala Glu 
1               5           


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide sequence

<400>  7

Ala Thr Asp Val Lys Gly Ala Glu 
1               5               


<210>  8
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide sequence

<400>  8

Ala Thr Leu Asp Ala Leu Leu Ala Ala Leu Arg Arg Ile Gln 
1               5                   10                  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide sequence

<400>  9

Cys Phe Phe Arg Gly Gly Phe Phe Asn His Asn Pro Arg Tyr Cys 
1               5                   10                  15  


